131 related articles for article (PubMed ID: 2875869)
1. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M
Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869
[TBL] [Abstract][Full Text] [Related]
2. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H
Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028
[TBL] [Abstract][Full Text] [Related]
3. Thyroid uptake of MIBG in Sipple's syndrome.
Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
[TBL] [Abstract][Full Text] [Related]
4. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract][Full Text] [Related]
5. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP
Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
[TBL] [Abstract][Full Text] [Related]
7. [Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
Izumi M; Kakezono F; Nagayama Y; Kiriyama T; Yokoyama N; Yamashita S; Morita S; Hirayu H; Kubo I; Ohtakara S
Kaku Igaku; 1986 Feb; 23(2):145-52. PubMed ID: 2872353
[No Abstract] [Full Text] [Related]
8. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
9. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
10. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).
Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G
J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168
[No Abstract] [Full Text] [Related]
11. Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy.
Namba H; Kondo H; Yamashita S; Kimura H; Yokoyama N; Tsuruta M; Sato A; Izumi M; Kinoshita H; Hakariya S
Ann Nucl Med; 1992 May; 6(2):111-5. PubMed ID: 1352456
[TBL] [Abstract][Full Text] [Related]
12. Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma.
Poston GJ; Fawcett HD; Townsend CM; James E; Lieg JL; Nusynowitz ML; Thompson JC
Life Sci; 1989; 44(21):1611-6. PubMed ID: 2786600
[TBL] [Abstract][Full Text] [Related]
13. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
Troncone L; Rufini V; De Rosa G; Testa A
Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
[TBL] [Abstract][Full Text] [Related]
15. Imaging of medullary thyroid cancer with 131I-MIBG.
Endo K; Shiomi K; Kasagi K; Konishi J; Torizuka K; Nakao K; Tanimura H
Lancet; 1984 Jul; 2(8396):233. PubMed ID: 6146795
[No Abstract] [Full Text] [Related]
16. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin.
Keeling CA; Basso LV
Clin Nucl Med; 1988 Apr; 13(4):260-3. PubMed ID: 2897264
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma: localization of a mediastinal metastasis with I-131 MIBG.
Laflamme L; Taillefer R; Duranceau A; Verdy M; Schürch W
Clin Nucl Med; 1988 Aug; 13(8):577-9. PubMed ID: 2901928
[TBL] [Abstract][Full Text] [Related]
19. (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
Lupoli G; Lombardi G; Panza N; Biondi B; Pacilio G; Lastoria S; Salvatore M
Med Oncol Tumor Pharmacother; 1991; 8(1):7-13. PubMed ID: 2041383
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
Ahuja S; Koppenhagen K; Ernst H
Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]